229
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Bronchial hyperresponsiveness in a population of north Finland with no previous diagnosis of asthma or chronic bronchitis assessed with histamine and methacholine tests

, , , &
Pages 308-317 | Received 22 Oct 2007, Accepted 22 Feb 2008, Published online: 01 Sep 2008

References

  • Koskela H. Cold air-provoked respiratory symptoms: the mechanisms and management. Int J Circumpolar Health 2007; 66 (2): 91–100.
  • Pallasaho P, Lundback B, Läspä SL, Jönsson E, Kotaniemi J, Sovijärvi ARA, et al. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki study. Respir Med 1999; 93: 798–809.
  • Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms and diseases: a comparative study between northern Sweden and northern Finland: report from the FinEsS study. Chest 2001; 119: 852–861.
  • Kotaniemi J, Latvala J, Lundbäck B, Sovijärvi A, Hassi J,Larsson K. Does living in a cold climate or recreational skiing increase the risk for obstructive respiratory diseases or symptoms? Int J Circumpolar Health 2003; 62 (2): 142–157.
  • Nieminen M. Unimodal distribution of bronchial hyper-responsiveness to methacholine in Asthmatic Patients. Chest 1992; 102: 1537–1543.
  • Sovijärvi ARA, Malmberg P, Reinikainen K, Rytilä P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in clinical material. Chest 1993; 104: 164–170.
  • Joos G, O’Connor B, ERS TASK FORCE 2003. Indirect airway challenges. Eur Respir J 2003; 21: 1050–1068.
  • Ryan G, Latimer K, Dolovich J, Hargreave F. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982; 37: 423–429.
  • Beach J, Young C, Avery A, Stenton S, Dennis J, Walters E, et al. Measurement of airway responsiveness to methacholine: relative importance of precision of drug delivery and the method of assessing response. Thorax 1993; 48 (3): 239–243.
  • Jögi R, Janson C, Hederström H. Comparison of two methacholine challenge methods using Spira-2 or Mefar dosimeter. Clin Physiol 1999; 19 (4): 300–304.
  • Wubbel C, Asmus M, Stevens G, et al. Methacholine challenge testing*. Comparison of the two American Thoracic Societyrecommended methods. Chest 2004; 125: 453–458.
  • The American Thoracic Society (ATS) Board of Directors. Guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med 2000; 161 (1): 309–329.
  • Juniper E, Frith P, Dunnett C, Cockcroft D, Hargreave F. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978; 33: 705–710.
  • Juniper E, Frith P, Hargreave F. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 198136:575–579.
  • Chatman M, Bleecker ER, Smith PL, Rosenthal RR, Mason P, Norman PS. A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects. Am Rev Respir Dis 1982; 126: 235–240.
  • Higgins BG, Britton JR, Chinn S, Jones TD, Vathenen AS, Burney PGJ, et al. Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax 1988; 43 (8): 605–610.
  • Griner P, Mayewski R, Mushlin A, Greenland P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med 198194 (4), part2:553–600.
  • Popa V, Singleton J. Provocation dose and discriminant analysis in histamine bronchoprovocation. Are the current predictive data satisfactory? Chest (1988)94: 466–475.
  • Brutsche M, Downs S, Schindler C, Gerbase M, Schwartz J, Frey M, et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006;61 (8): 671–677.
  • Kotaniemi J, Lundback B, Nieminen M, Sovijarvi ARA, Laitinen LA. Increase of asthma in adults in northern Finland? - a report from the FinEsS study. Allergy 2001; 56: 169–174.
  • Viljanen AA, Haltunen PK, Kreus K-E, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scan J Clin Lab Invest 41 1982; 159: 5–20.
  • The American Thoracic Society (ATS). Standardization of spirometry (1994). Am J Respir Crit Care Med 1995; 152: 1107–1136.
  • Cockcroft DW, Murdock KY, Mink JT. Determination of Histamine PC20. Comparison of linear and logarithmic interpolation. Chest 1983; 84 (4): 505–506.
  • Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235–243.
  • Jokic R, Davis E, Cockcroft D. Methacholine PC20 extrapolation. Chest 1998; 114 (6): 1796–1797.
  • Sovijärvi A, Malmberg P, Reinikainen K, Rytila P, Poppius H. Nopea dosimetrinen histamiinialtistuskoe astman diagnostiikkaan. Duodecim 1993: 109:991–998.
  • Hedman J, Poussa T, Nieminen M. A rapid dosimetric methacholine challenge in asthma diagnostics: a clinical study of 230 patients with dyspnoea, wheezing or a cough of unknown cause. Respir Med 1998; 92: 32–39.
  • Peat JK, Unger W, Combe D. Measuring changes in logarithmic data, with special reference to bronchial responsiveness. J Clin Epidemiol 1994;47(10):1099–1108.
  • Altman D, Bland J. Measurement in medicine: the analysis of method comparison studies. The Statistician 1983; 32: 307–317.
  • Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 8: 307–310.
  • Liebetrau AM. Measures of association. Thousand Oaks, CA: Sage Publications; 1983.96 pp.
  • Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: John Wiley and Sons; 2000.373 pp.
  • Norrman E, Plaschke P, Bjornsson E, Resenhall L, Lundback B, Jansson C, et al. Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden. Respir Med (1998) ;92 (3): 480–487.
  • Koh Y, Kang E, Kang H, Yoo Y, Park Y, Kim C. Bronchial hyperresponsiveness in adolescents with long-term asthma remission. Importance of a family history of bronchial hyperresponsiveness. Chest 2003; 124: 819–825.
  • Holroyd K, Martinati L, Trabetti E Scherpbier T, Eleff SM, Boner AL, et al. Asthma and bronchial hyperre-sponsiveness linked to the XY long arm pseudoauto-somal region. Genomics 1998; 52: 233–235.
  • Kurzius-Spencer M, Holberg C, Sherril D, Carrozzi L, Di Pede F, Baldacci S, et al. Segregation analysis of bronchial hyperresponsiveness in a general population in north Italy. Am J Med Genet 2004;125A(3): 232–239.
  • Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991; 4: 257–266.
  • Nieminen M, Holli H, Lahdensuo A, Muittari A, Karvonen J. Aerosol deposition in automatic dosimeter nebulization. Eur J Respir Dis 1987; 71: 145–152.
  • Nieminen M, Lahdensuo A, Kellomaki L, Karvonen J, Muittari A. Methacholine bronchial challenge using a dosimeter with controlled tidal breathing. Thorax 1988; 43: 896–900.
  • Chinn S, Schouten JP. Reproducibility of non-spesific bronchial challenge in adults: implications for desing, analysis and interpretation of clinical and epidemiological studies. Thorax 200560:395–400.
  • Woolcock A, Salome C, Yan K. The shape of the doseresponse curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984; 130: 71–75.
  • Sterk PJ, Daniel EE, Zamel N, Hargreave FE. Limited maximal airway narrowing in nonasthmatic subjects: the role of neural control and prostaglandin release. Am Rev Respir Dis 1985; 132: 865–870.
  • Lougheed M, Pearce-Pinto G, Klerk N, Ryan G, Musk A, James A. Variability of the plateau response to methacholine in subjects without respiratory symptoms. Thorax 1993; 48: 512–517.